Quick Answer
Virax Biolabs Group Ltd reported Gross Profit of -$53.1 thousand for the year ending 2025.
- Virax Biolabs Group Ltd showed a decrease of -204.9% in Gross Profit from 2024 to 2025.
- This data is from Virax Biolabs Group Ltd's annual report (Form 10-K), filed with the SEC on July 2, 2025.
- XBRL data for this metric is available from 2021 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2021 to 2025), Virax Biolabs Group Ltd's Gross Profit has declined by 462.5%.
- Historical annual values: Fiscal year 2025: -$53.1 thousand | Fiscal year 2024: $50.6 thousand | Fiscal year 2023: -$1.4 thousand | Fiscal year 2021: -$9.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: